Cossery Jean-Michel 4

What Happened
Jean‑Michel Cossery, a director of SOPHiA GENETICS SA (SOPH), received equity awards on June 18, 2026: 19,724 restricted stock units (RSUs) valued at $5.46 each (total ≈ $107,693) and 28,818 share options (derivative) at $5.46 each (total ≈ $157,346). These transactions are awards/grants (acquisitions), not open‑market purchases or sales.

Key Details

• Transaction date: June 18, 2026; Filing date: June 22, 2026 (filed within required time).
• RSU grant: 19,724 RSUs @ $5.46 = $107,693. (Footnote: Each RSU converts to one ordinary share on vesting; contingent on continued service.)
• Option grant (derivative): 28,818 share options @ $5.46 = $157,346. (Footnote: Options were granted and vest 100% as of the issuer’s next scheduled annual meeting, contingent on continued service.)
• Total grant value reported (grant-date basis): ≈ $265,039.
• Shares owned after the transaction: Not specified in the provided filing details.
• Filing timeliness: Report appears timely (filed within the standard two business days after the June 18 transaction).

Context

• RSUs are a promise to deliver shares upon vesting (no immediate cash paid by the insider). Stock options are a derivative right to acquire shares in the future if exercised. Both awards vest 100% as of the company’s next annual meeting, subject to continued service.
• Awards to directors are common as part of compensation and do not by themselves indicate intent to buy or sell shares.